DrugDev, a global network of clinical trial physicians, has acquired TrialNetworks to boost its business by adding more clinical trials system capabilities.
IMS Health has acquired Forcea, a European provider of business intelligence and analytics, to boost its performance improvement capabilities for customers.
In the slightly head-scratching acquisition department, Quintiles, a large contract research and drug and device services firm, is acquiring Encore Health Resources, which consults mostly with providers in regard to EHR implementation and other IT needs. Quintiles says it will improve access to real-world data about drug use.
SolveBio has raised $2 million to develop its business of collecting and cleaning up genomic data to be used as a reference set for providers and developers.
Altarum Institute's March health price report (which tracks only the price component of health spending growth) shows a muted year-over-year increase of only 1.1%, indicating that utilization is the primary cause of the overall 7% spending growth.
Magellan Rx Management has issued its fourth annual Medical Pharmacy Trend Report, which focuses on drugs paid under the medical benefit side of a health plan and finds continuing double-digit growth and the spread of various management techniques.
Onward Behavioral Health, which is owned by a PE firm, has been sold to Pyramid Healthcare, also owned by a PE firm and also in the behavioral health business.
Google Ventures is leading a$130 million investment into Flatiron Health, an oncology data company, which will use the funding in part to acquire Altos Solutions, a provider of oncology EMRs.
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.